Skip to main navigation Skip to search Skip to main content

Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors

Research output: Contribution to journalArticle

Abstract

The presence of epidermal growth factor, estrogen, and progesterone receptors (EGFR, ER, and PR) was investigated by a competitive binding assay in 43 colorectal adenocarcinomas and 32 normal colorectal mucosa specimens. EGFR were expressed in most of the tumor specimens analyzed at levels comparable with normal mucosa. There was no correlation between EGFR and tumor localization, tumor size, tumor stage, and grading. Among tumor specimens, 13.9% and 6.9% expressed very low but detectable ER and PR levels, respectively. No statistically significant difference was found between steroid hormone receptor levels in the tumor and normal mucosa specimens, and neither was there any correlation of ER and PR with the pathological findings. Our results suggest that the EGFR system may play a role in regulating the growth of colorectal tissues. Further studies should demonstrate whether, despite the lack of correlation with histopathological parameters, EGFR expression may have a biological significance in human colorectal cancer.
Original languageEnglish
Pages (from-to)183-187
Number of pages5
JournalJournal of Surgical Oncology
Volume48
Publication statusPublished - 1991

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adenocarcinoma
  • Aged
  • Aged, 80 and over
  • Binding, Competitive
  • Colorectal Neoplasms
  • Female
  • Humans
  • Intestinal Mucosa
  • Male
  • Middle Aged
  • Radioligand Assay
  • Receptor, Epidermal Growth Factor
  • Receptors, Estrogen
  • Receptors, Progesterone

Fingerprint

Dive into the research topics of 'Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors'. Together they form a unique fingerprint.

Cite this